Clinical oncology testing

QIAGEN Clinical Insight (QCI™) is an advanced enterprise software platform specifically designed for pro­duction-scale, clinical-grade genomic testing laboratories. QCI Interpret is a secure, scalable, web-based clinical decision support solution that offers best-in-class interpreta­tion and reporting of NGS cancer test results.

› Beat somatic cancer

› Fight hereditary cancer

Request a consultation


Increased NGS
test throughput

For clinical cancer testing, our platform reduces the time required to accurately interpret a patient’s test result from hours or days to less than 15 minutes per test. These efficiencies translate to sub­stantial increases in test reporting throughput by reducing turnaround time without compromising quality or reporting standards.

› Learn about higher throughput 

Clinical labs rolling out NGS-based tests are confronted with two key challenges: the complexity of turning molecular profiling information into precise medical recommendations, and the time and effort it takes to generate actionable reports. QIAGEN Clinical Insight provides a rich and detailed, yet very clear and concise, report that suggests management and treatment options based on the patient’s gene variations that profile their disease and outline causal links. It is this kind of interpretation that gives clinical value to the data, and what enables the actual insights into a patient’s specific disease and treatment options.


Madhuri Hegde, PhD, FACMG

Professor of Human Genetics at the Emory University School of Medicine and Executive Director of the Emory Genetics Laboratory

Get actionable cancer insights


© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers